Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma
Br J Dermatol
.
2017 Nov;177(5):1150-1151.
doi: 10.1111/bjd.15932.
Authors
C A Harwood
1
,
S T Arron
1
,
C M Proby
1
,
M M Asgari
1
,
J N Bouwes Bavinck
1
,
A C Green
1
,
A E Toland
1
;
KeraCon Consortium
Affiliation
1
Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
PMID:
29192981
PMCID:
PMC7720813
DOI:
10.1111/bjd.15932
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Squamous Cell
Humans
Immunosuppression Therapy*
Keratinocytes*
Organ Transplantation
Skin Neoplasms
Grants and funding
13044/CRUK_/Cancer Research UK/United Kingdom
K24 AR069760/AR/NIAMS NIH HHS/United States